Copyright
©The Author(s) 2024.
World J Gastroenterol. Jun 7, 2024; 30(21): 2817-2826
Published online Jun 7, 2024. doi: 10.3748/wjg.v30.i21.2817
Published online Jun 7, 2024. doi: 10.3748/wjg.v30.i21.2817
Figure 4 Anxiety- and depressive-like behaviors in wild-type mice chronically infected with colibactin-producing Escherichia coli.
A and B: Anxiety-like behavior assessed using the elevated plus maze test at 14 DPI; A: Entry frequency and B: time spent in the open arms of wild-type (WT) control and infected mice (n = 12 per group); C: Immobility time during the forced swimming test of WT control and infected mice (n = 12 per group) at 35 DPI; D-F: WT control and infected (n = 6 per group) mice were placed in a PhenoTyper® device at 20 DPI and recorded for 24 h to assess spontaneous behavior in a representative experiment; D and E: Total digging (D) and sniffing times (E) determined over 24 h; F and G: Mean digging (F) and sniffing times (G) measured only during the 12-h dark period. The white circles represent WT control mice, while the black circles represent infected mice. Statistical analysis: Student’s t test: aP < 0.05, bP < 0.01, cP < 0.001, dP < 0.0001.
- Citation: Rondepierre F, Meynier M, Gagniere J, Deneuvy V, Deneuvy A, Roche G, Baudu E, Pereira B, Bonnet R, Barnich N, Carvalho FA, Pezet D, Bonnet M, Jalenques I. Preclinical and clinical evidence of the association of colibactin-producing Escherichia coli with anxiety and depression in colon cancer. World J Gastroenterol 2024; 30(21): 2817-2826
- URL: https://www.wjgnet.com/1007-9327/full/v30/i21/2817.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i21.2817